102 related articles for article (PubMed ID: 2433473)
1. [Immunohistochemical study of oncogene-related products in human gastrointestinal malignancies--expression of ras p 21, fes p 85 and EGF receptor].
Kitagami S; Itabashi M; Hirota T; Hayashi I; Hojo K; Moriya Y; Maruyama K; Okabayashi K
Gan No Rinsho; 1986 Dec; 32(15):1950-8. PubMed ID: 2433473
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.
Nakajima K; Kuzumaki N; Oda A; Kobayashi H; Katoh H; Tanabe T
Oncology; 1989; 46(4):260-5. PubMed ID: 2662090
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.
Yasui W; Sumiyoshi H; Hata J; Kameda T; Ochiai A; Ito H; Tahara E
Cancer Res; 1988 Jan; 48(1):137-41. PubMed ID: 2446740
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
Williams AR; Piris J; Spandidos DA; Wyllie AH
Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Ha-ras oncogene product, p21 in gastric carcinoma].
Ebihara T; Koyama S; Osuga T
Nihon Shokakibyo Gakkai Zasshi; 1987 Sep; 84(9):1737-9. PubMed ID: 3323578
[No Abstract] [Full Text] [Related]
8. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
Nakajima K
Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.
Allen DC; Foster H; Orchin JC; Biggart JD
J Clin Pathol; 1987 Feb; 40(2):157-62. PubMed ID: 3546394
[TBL] [Abstract][Full Text] [Related]
10. Detection of ras gene alterations and ras proteins in colorectal cancer.
Salhab N; Jones DJ; Bos JL; Kinsella A; Schofield PF
Dis Colon Rectum; 1989 Aug; 32(8):659-64. PubMed ID: 2666051
[TBL] [Abstract][Full Text] [Related]
11. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of CEA staining in gastric and colorectal cancer tissues.
Kojima O; Tanioku T; Kitagawa N; Uehara Y; Majima T; Ikeda E; Iwai N; Fujita Y; Majima S
Gastroenterol Jpn; 1984 Feb; 19(1):18-23. PubMed ID: 6202582
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ha-ras oncogene product in rat gastrointestinal carcinomas induced by chemical carcinogens.
Yasui W; Sumiyoshi H; Yamamoto T; Oda N; Kameda T; Tanaka T; Tahara E
Acta Pathol Jpn; 1987 Nov; 37(11):1731-41. PubMed ID: 3501927
[TBL] [Abstract][Full Text] [Related]
14. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas.
Czerniak B; Herz F; Koss LG; Schlom J
Cancer; 1987 Nov; 60(10):2432-6. PubMed ID: 3311346
[TBL] [Abstract][Full Text] [Related]
15. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.
Kerr IB; Lee FD; Quintanilla M; Balmain A
Br J Cancer; 1985 Nov; 52(5):695-700. PubMed ID: 3904802
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of the ras oncogene expression in human breast lesions.
Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.
Mitani S; Sugawara I; Shiku H; Mori S
Cancer; 1988 Nov; 62(10):2085-93. PubMed ID: 3052780
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric analysis of oncogene products].
Tsuchiya H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2352-9. PubMed ID: 2665653
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
